Muhammad Bilal Abid

2.2k total citations · 1 hit paper
68 papers, 762 citations indexed

About

Muhammad Bilal Abid is a scholar working on Oncology, Infectious Diseases and Surgery. According to data from OpenAlex, Muhammad Bilal Abid has authored 68 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Infectious Diseases and 14 papers in Surgery. Recurrent topics in Muhammad Bilal Abid's work include Hematopoietic Stem Cell Transplantation (10 papers), CAR-T cell therapy research (10 papers) and Multiple Myeloma Research and Treatments (7 papers). Muhammad Bilal Abid is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), CAR-T cell therapy research (10 papers) and Multiple Myeloma Research and Treatments (7 papers). Muhammad Bilal Abid collaborates with scholars based in United States, Singapore and Pakistan. Muhammad Bilal Abid's co-authors include Muhammad Abbas Abid, Ikram Hussain, Gunjan L. Shah, Roy F. Chemaly, Christopher E. Dandoy, Parameswaran Hari, Neel S. Bhatt, Lohith Gowda, Calvin Jianyi Koh and Andrew St. Martin and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Muhammad Bilal Abid

60 papers receiving 747 citations

Hit Papers

Clinical characteristics and outcomes of COVID-19 in haem... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
    2021 202 citations Muhammad Bilal Abid et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muhammad Bilal Abid United States 15 363 294 115 104 82 68 762
Noam Benyamini Israel 17 289 0.8× 451 1.5× 310 2.7× 99 1.0× 144 1.8× 53 963
Wolmar Pulcheri Brazil 16 234 0.6× 280 1.0× 161 1.4× 74 0.7× 237 2.9× 41 824
Frankie Wai Tsoi Cheng Hong Kong 19 423 1.2× 114 0.4× 78 0.7× 179 1.7× 324 4.0× 68 1.2k
Duaa W. Al‐Sadeq Qatar 16 569 1.6× 178 0.6× 22 0.2× 129 1.2× 198 2.4× 35 998
Ali Bay Türkiye 19 224 0.6× 114 0.4× 337 2.9× 52 0.5× 254 3.1× 90 969
Álvaro H. Borges Denmark 13 424 1.2× 210 0.7× 28 0.2× 67 0.6× 233 2.8× 37 936
Antonella Colombini Italy 15 188 0.5× 175 0.6× 110 1.0× 91 0.9× 154 1.9× 39 698
Isabel Sánchez‐Ortega Spain 17 326 0.9× 454 1.5× 374 3.3× 79 0.8× 404 4.9× 50 1.1k
Alain Makinson France 19 474 1.3× 253 0.9× 21 0.2× 65 0.6× 379 4.6× 84 1.1k
Nack‐Gyun Chung South Korea 17 116 0.3× 226 0.8× 431 3.7× 118 1.1× 167 2.0× 117 1.0k

Countries citing papers authored by Muhammad Bilal Abid

Since Specialization
Citations

This map shows the geographic impact of Muhammad Bilal Abid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Bilal Abid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Bilal Abid more than expected).

Fields of papers citing papers by Muhammad Bilal Abid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Bilal Abid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Bilal Abid. The network helps show where Muhammad Bilal Abid may publish in the future.

Co-authorship network of co-authors of Muhammad Bilal Abid

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Bilal Abid. A scholar is included among the top collaborators of Muhammad Bilal Abid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Bilal Abid. Muhammad Bilal Abid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suelzer, Elizabeth, et al.. (2024). Efficacy of SARS-CoV-2 Vaccine Doses in Allogeneic Hemopoietic Stem Cell Recipients: A Systematic Review and Meta-Analysis. Asian Pacific Journal of Cancer Prevention. 25(2). 393–399. 3 indexed citations
2.
Abid, Muhammad Bilal, Noel Estrada‐Merly, Mei‐Jie Zhang, et al.. (2023). Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia. Transplantation and Cellular Therapy. 29(9). 578.e1–578.e9. 9 indexed citations
3.
Wu, James Fan, et al.. (2023). Impact of age on efficacy and safety of chimeric antigen receptor‐T in B‐cell acute lymphoblastic leukaemia—A systematic review and meta‐analysis. British Journal of Haematology. 203(5). e117–e120. 1 indexed citations
4.
Abid, Muhammad Bilal, Anikó Szabó, Walter Longo, et al.. (2023). Efficacy of Multiple SARS-CoV-2 Vaccine Doses in Patients with B Cell Hematologic Malignancies Receiving Chimeric Antigen Receptor T Cell Therapy: A Contemporary Cohort Analysis. Transplantation and Cellular Therapy. 30(3). 285–297. 9 indexed citations
5.
Abid, Muhammad Abbas, et al.. (2022). Climate change and the increased burden of dengue fever in Pakistan. The Lancet Infectious Diseases. 23(1). 17–18. 15 indexed citations
6.
Muhsen, Ibrahim N., Muhammad Bilal Abid, Ali Alahmari, et al.. (2022). Infectious Complications and Preventative Strategies following Chimeric Antigen Receptor T-cells (CAR-T cells) Therapy for B-Cell Malignancies. Hematology/Oncology and Stem Cell Therapy. 15(3). 153–158. 6 indexed citations
7.
Abid, Muhammad Abbas, et al.. (2021). State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses. Transplantation and Cellular Therapy. 27(12). 973–987. 31 indexed citations
8.
Abid, Muhammad Abbas, et al.. (2021). SARS‐CoV‐2 vaccine response in CAR T‐cell therapy recipients: A systematic review and preliminary observations. Hematological Oncology. 40(2). 287–291. 21 indexed citations
9.
Abid, Muhammad Bilal. (2021). Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations. Journal for ImmunoTherapy of Cancer. 9(4). e002307–e002307. 8 indexed citations
10.
Abid, Muhammad Abbas, et al.. (2020). Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline. Frontiers in Immunology. 11. 1294–1294. 17 indexed citations
11.
Abid, Muhammad Bilal, Saurabh Chhabra, Blake W. Buchan, et al.. (2020). Bronchoalveolar lavage-based COVID-19 testing in patients with cancer. Hematology/Oncology and Stem Cell Therapy. 14(1). 65–70. 14 indexed citations
12.
Abid, Muhammad Abbas, et al.. (2019). Herpetic optic perineuritis presenting as classic abducens nerve palsy. SHILAP Revista de lepidopterología. 8(1). 228–229. 4 indexed citations
13.
Abid, Muhammad Bilal, Sanjay De Mel, Eng Soo Yap, et al.. (2018). Pegylated Filgrastim Versus Filgrastim for Stem Cell Mobilization in Multiple Myeloma After Novel Agent Induction. Clinical Lymphoma Myeloma & Leukemia. 18(3). 174–179. 4 indexed citations
14.
Abid, Muhammad Bilal, Muhammad Bilal Abid, Muhammad Abbas Abid, et al.. (2017). Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?. Hematological Oncology. 36(1). 320–323. 6 indexed citations
15.
Abid, Muhammad Bilal, et al.. (2017). Alemtuzumab-based therapy for Secondary Malignant Histiocytosis arising from Pre-B-ALL. Leukemia Research Reports. 9. 5–8.
16.
Abid, Muhammad Bilal, Muhammad Bilal Abid, Sanjay De Mel, et al.. (2016). Bortezomib-related neuropathy may mask CNS relapse in multiple myeloma: A call for diligence. Cancer Biology & Therapy. 17(7). 723–726. 1 indexed citations
17.
Abid, Muhammad Bilal, et al.. (2015). Disseminated Cryptococcal infection in an immunocompetent host mimicking plasma cell disorder: a case report and literature review. Clinical Lymphoma Myeloma & Leukemia. 15. e208–e209. 1 indexed citations
18.
Abid, Muhammad Bilal, et al.. (2010). Abcès de la paroi thoracique et abdominale isolé : une forme exceptionnelle de tuberculose. Revue des Maladies Respiratoires. 27(1). 72–75. 9 indexed citations
19.
Abid, Muhammad Bilal, et al.. (2010). [Intestinal perforation in a Tunisian woman: peritonitis due to a fishbone].. PubMed. 70(1). 77–9. 1 indexed citations
20.
Abid, Muhammad Bilal, S. O’Brien, Elizabeth H. Boxall, & Susan J. Skidmore. (1997). Hepatitis and Travel Abroad: A Case Report. Journal of Travel Medicine. 4(4). 187–188. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noam Benyamini Breakdown of academic impact, for papers by Wolmar Pulcheri Breakdown of academic impact, for papers by Frankie Wai Tsoi Cheng Breakdown of academic impact, for papers by Duaa W. Al‐Sadeq Breakdown of academic impact, for papers by Ali Bay Breakdown of academic impact, for papers by Álvaro H. Borges Breakdown of academic impact, for papers by Antonella Colombini Breakdown of academic impact, for papers by Isabel Sánchez‐Ortega Breakdown of academic impact, for papers by Alain Makinson Breakdown of academic impact, for papers by Nack‐Gyun Chung
Rankless by CCL
2026